{"transactions":[{"id":763821,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T23:33:30.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":85558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of\nthe shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":85558,"derivative":{"exercise_price":1.89,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":85558},"source":{"system":"sec-edgar","filing":"0001301120-26-000021","document":"wk-form4_1779838407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000021/wk-form4_1779838407.xml","form_type":"4"}},{"id":829388,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-24T23:24:24.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":267686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-26-000018","document":"wk-form4_1774394662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000018/wk-form4_1774394662.xml","form_type":"4"}},{"id":829387,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-24T23:24:24.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":2.8566,"value":18567.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $3.03. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000018","document":"wk-form4_1774394662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000018/wk-form4_1774394662.xml","form_type":"4"}},{"id":829386,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-24T23:24:24.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-26-000018","document":"wk-form4_1774394662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000018/wk-form4_1774394662.xml","form_type":"4"}},{"id":832379,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T18:20:45.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":false,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":274186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001301120-26-000016","document":"wk-form4_1774030842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000016/wk-form4_1774030842.xml","form_type":"4"}},{"id":832378,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-20T18:20:45.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":39000,"price":2.5,"value":97500.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000016","document":"wk-form4_1774030842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000016/wk-form4_1774030842.xml","form_type":"4"}},{"id":832377,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-20T18:20:45.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":true,"shares":39000,"price":0.06,"value":2340.0,"ownership":{"direct":true},"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001301120-26-000016","document":"wk-form4_1774030842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000016/wk-form4_1774030842.xml","form_type":"4"}},{"id":901083,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T13:35:57.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":69000,"derivative":{"exercise_price":2.76,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0001301120-26-000014","document":"wk-form4_1771335355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000014/wk-form4_1771335355.xml","form_type":"4"}},{"id":921941,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T17:35:37.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":313186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-26-000012","document":"wk-form4_1770140133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000012/wk-form4_1770140133.xml","form_type":"4"}},{"id":921940,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-03T17:35:37.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":3.0277,"value":19680.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.00. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000012","document":"wk-form4_1770140133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000012/wk-form4_1770140133.xml","form_type":"4"}},{"id":921939,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-03T17:35:37.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-26-000012","document":"wk-form4_1770140133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000012/wk-form4_1770140133.xml","form_type":"4"}},{"id":927911,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-29T17:54:00.000Z","date":"2026-01-28","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":319686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-26-000010","document":"wk-form4_1769709237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000010/wk-form4_1769709237.xml","form_type":"4"}},{"id":927910,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-29T17:54:00.000Z","date":"2026-01-28","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":3.567,"value":23185.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.55. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000010","document":"wk-form4_1769709237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000010/wk-form4_1769709237.xml","form_type":"4"}},{"id":927909,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-29T17:54:00.000Z","date":"2026-01-28","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-26-000010","document":"wk-form4_1769709237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000010/wk-form4_1769709237.xml","form_type":"4"}},{"id":932318,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-23T17:35:09.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":326186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001301120-26-000008","document":"wk-form4_1769189706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000008/wk-form4_1769189706.xml","form_type":"4"}},{"id":932317,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-23T17:35:09.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":2.95,"value":7375.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000008","document":"wk-form4_1769189706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000008/wk-form4_1769189706.xml","form_type":"4"}},{"id":932316,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-23T17:35:09.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":0.06,"value":150.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001301120-26-000008","document":"wk-form4_1769189706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000008/wk-form4_1769189706.xml","form_type":"4"}},{"id":934235,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":328686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":934234,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":330686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":934233,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":3,"value":6000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":934232,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":0.06,"value":120.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":934231,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":3.07,"value":6140.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":934230,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-22T00:17:14.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":0.06,"value":120.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001301120-26-000006","document":"wk-form4_1769041031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000006/wk-form4_1769041031.xml","form_type":"4"}},{"id":939227,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-14","kind":"exercise","planned":true,"acquired":false,"shares":1084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":332686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":1084},"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":939226,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-13","kind":"exercise","planned":true,"acquired":false,"shares":5416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":333770,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":5416},"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":939225,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-14","kind":"sale","planned":true,"acquired":false,"shares":1084,"price":2.5031,"value":2713.3604,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.50. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":939224,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-14","kind":"exercise","planned":true,"acquired":true,"shares":1084,"price":0.06,"value":65.04,"ownership":{"direct":true},"balance_after":1084,"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":939223,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-13","kind":"sale","planned":true,"acquired":false,"shares":5416,"price":2.5,"value":13540.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":939222,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-14T17:56:48.000Z","date":"2026-01-13","kind":"exercise","planned":true,"acquired":true,"shares":5416,"price":0.06,"value":324.96,"ownership":{"direct":true},"balance_after":5416,"source":{"system":"sec-edgar","filing":"0001301120-26-000004","document":"wk-form4_1768413405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000004/wk-form4_1768413405.xml","form_type":"4"}},{"id":942146,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T17:27:30.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":339186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001301120-26-000002","document":"wk-form4_1767979647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000002/wk-form4_1767979647.xml","form_type":"4"}},{"id":942145,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-09T17:27:30.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":13000,"price":2.6887,"value":34953.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.60. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.60. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-26-000002","document":"wk-form4_1767979647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000002/wk-form4_1767979647.xml","form_type":"4"}},{"id":942144,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-09T17:27:30.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":0.06,"value":780.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001301120-26-000002","document":"wk-form4_1767979647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112026000002/wk-form4_1767979647.xml","form_type":"4"}},{"id":958229,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-29T16:40:10.000Z","date":"2025-12-23","kind":"exercise","planned":true,"acquired":false,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":352186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001301120-25-000039","document":"wk-form4_1767026407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000039/wk-form4_1767026407.xml","form_type":"4"}},{"id":958228,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-29T16:40:10.000Z","date":"2025-12-23","kind":"sale","planned":true,"acquired":false,"shares":4100,"price":2.6,"value":10660.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000039","document":"wk-form4_1767026407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000039/wk-form4_1767026407.xml","form_type":"4"}},{"id":958227,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-29T16:40:10.000Z","date":"2025-12-23","kind":"exercise","planned":true,"acquired":true,"shares":4100,"price":0.06,"value":246.0,"ownership":{"direct":true},"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001301120-25-000039","document":"wk-form4_1767026407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000039/wk-form4_1767026407.xml","form_type":"4"}},{"id":959666,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T19:04:33.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":false,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":356286,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001301120-25-000037","document":"wk-form4_1766516671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000037/wk-form4_1766516671.xml","form_type":"4"}},{"id":959665,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-23T19:04:33.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":5673,"price":2.6737,"value":15167.9001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.705 to $2.66. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000037","document":"wk-form4_1766516671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000037/wk-form4_1766516671.xml","form_type":"4"}},{"id":959664,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-23T19:04:33.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":true,"shares":5673,"price":0.06,"value":340.38,"ownership":{"direct":true},"balance_after":5673,"source":{"system":"sec-edgar","filing":"0001301120-25-000037","document":"wk-form4_1766516671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000037/wk-form4_1766516671.xml","form_type":"4"}},{"id":965079,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-18T00:56:57.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":false,"shares":3227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":361959,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":3227},"source":{"system":"sec-edgar","filing":"0001301120-25-000035","document":"wk-form4_1766019414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000035/wk-form4_1766019414.xml","form_type":"4"}},{"id":965078,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:56:57.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":3227,"price":2.9631,"value":9561.9237,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $2.96. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000035","document":"wk-form4_1766019414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000035/wk-form4_1766019414.xml","form_type":"4"}},{"id":965077,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:56:57.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":true,"shares":3227,"price":0.06,"value":193.62,"ownership":{"direct":true},"balance_after":3227,"source":{"system":"sec-edgar","filing":"0001301120-25-000035","document":"wk-form4_1766019414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000035/wk-form4_1766019414.xml","form_type":"4"}},{"id":967605,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-16T23:59:24.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":365186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001301120-25-000033","document":"wk-form4_1765929561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000033/wk-form4_1765929561.xml","form_type":"4"}},{"id":967604,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:59:24.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":3.2597,"value":5541.49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.275. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000033","document":"wk-form4_1765929561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000033/wk-form4_1765929561.xml","form_type":"4"}},{"id":967603,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:59:24.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":true,"shares":1700,"price":0.06,"value":102.0,"ownership":{"direct":true},"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001301120-25-000033","document":"wk-form4_1765929561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000033/wk-form4_1765929561.xml","form_type":"4"}},{"id":971253,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-12T17:48:08.000Z","date":"2025-12-11","kind":"exercise","planned":true,"acquired":false,"shares":3555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":366886,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":3555},"source":{"system":"sec-edgar","filing":"0001301120-25-000030","document":"wk-form4_1765561686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000030/wk-form4_1765561686.xml","form_type":"4"}},{"id":971252,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-12T17:48:08.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":3555,"price":3.2404,"value":11519.622,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.35. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000030","document":"wk-form4_1765561686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000030/wk-form4_1765561686.xml","form_type":"4"}},{"id":971251,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-12T17:48:08.000Z","date":"2025-12-11","kind":"exercise","planned":true,"acquired":true,"shares":3555,"price":0.06,"value":213.3,"ownership":{"direct":true},"balance_after":3555,"source":{"system":"sec-edgar","filing":"0001301120-25-000030","document":"wk-form4_1765561686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000030/wk-form4_1765561686.xml","form_type":"4"}},{"id":972678,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":false,"shares":645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":370441,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":645},"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":972677,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":371086,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":972676,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":645,"price":3.35,"value":2160.75,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":972675,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-10","kind":"grant","planned":true,"acquired":true,"shares":645,"price":0.06,"value":38.7,"ownership":{"direct":true},"balance_after":645,"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":972674,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":600,"price":3.3133,"value":1987.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.315. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":972673,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:11:24.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":600,"price":0.06,"value":36.0,"ownership":{"direct":true},"balance_after":600,"source":{"system":"sec-edgar","filing":"0001301120-25-000027","document":"wk-form4_1765487480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000027/wk-form4_1765487480.xml","form_type":"4"}},{"id":980337,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":371686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":980336,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":376686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":980335,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":3.5246,"value":17623.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to $3.55. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to $3.55. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":980334,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.06,"value":300.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":980333,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":3.9052,"value":5857.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.9112. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":980332,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:56:00.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":1500,"price":0.06,"value":90.0,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001301120-25-000025","document":"wk-form4_1764896157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000025/wk-form4_1764896157.xml","form_type":"4"}},{"id":987019,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-26T22:21:54.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":5965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":378186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":5965},"source":{"system":"sec-edgar","filing":"0001301120-25-000023","document":"wk-form4_1764195711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000023/wk-form4_1764195711.xml","form_type":"4"}},{"id":987018,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-26T22:21:54.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":5965,"price":3.9001,"value":23264.0965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.91. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":5965,"source":{"system":"sec-edgar","filing":"0001301120-25-000023","document":"wk-form4_1764195711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000023/wk-form4_1764195711.xml","form_type":"4"}},{"id":987017,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-26T22:21:54.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":5965,"price":0.06,"value":357.9,"ownership":{"direct":true},"balance_after":11930,"source":{"system":"sec-edgar","filing":"0001301120-25-000023","document":"wk-form4_1764195711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000023/wk-form4_1764195711.xml","form_type":"4"}},{"id":988728,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-26T02:20:06.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":384151,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":535},"source":{"system":"sec-edgar","filing":"0001628280-25-054059","document":"wk-form4_1764123603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000162828025054059/wk-form4_1764123603.xml","form_type":"4"}},{"id":988727,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-26T02:20:06.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":535,"price":3.935,"value":2105.225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.98 to $3.917. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-054059","document":"wk-form4_1764123603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000162828025054059/wk-form4_1764123603.xml","form_type":"4"}},{"id":988726,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-26T02:20:06.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":535,"price":0.06,"value":32.1,"ownership":{"direct":true},"balance_after":535,"source":{"system":"sec-edgar","filing":"0001628280-25-054059","document":"wk-form4_1764123603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000162828025054059/wk-form4_1764123603.xml","form_type":"4"}},{"id":993862,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-19T18:47:46.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":384686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-25-000021","document":"wk-form4_1763578063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000021/wk-form4_1763578063.xml","form_type":"4"}},{"id":993861,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-19T18:47:46.000Z","date":"2025-11-18","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":3.7541,"value":24401.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.71. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000021","document":"wk-form4_1763578063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000021/wk-form4_1763578063.xml","form_type":"4"}},{"id":993860,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-19T18:47:46.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-25-000021","document":"wk-form4_1763578063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000021/wk-form4_1763578063.xml","form_type":"4"}},{"id":1002053,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-12T17:38:16.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":391186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-25-000019","document":"wk-form4_1762969093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000019/wk-form4_1762969093.xml","form_type":"4"}},{"id":1002052,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-12T17:38:16.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":4.1,"value":26650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.00. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000019","document":"wk-form4_1762969093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000019/wk-form4_1762969093.xml","form_type":"4"}},{"id":1002051,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-12T17:38:16.000Z","date":"2025-11-10","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-25-000019","document":"wk-form4_1762969093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000019/wk-form4_1762969093.xml","form_type":"4"}},{"id":1005845,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-06T21:40:25.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":false,"shares":3398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":397686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":3398},"source":{"system":"sec-edgar","filing":"0001301120-25-000017","document":"wk-form4_1762465222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000017/wk-form4_1762465222.xml","form_type":"4"}},{"id":1005844,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-06T21:40:25.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":3398,"price":4.24,"value":14407.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.225. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000017","document":"wk-form4_1762465222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000017/wk-form4_1762465222.xml","form_type":"4"}},{"id":1005843,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-06T21:40:25.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":true,"shares":3398,"price":0.06,"value":203.88,"ownership":{"direct":true},"balance_after":3398,"source":{"system":"sec-edgar","filing":"0001301120-25-000017","document":"wk-form4_1762465222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000017/wk-form4_1762465222.xml","form_type":"4"}},{"id":1006853,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-05T20:29:36.000Z","date":"2025-11-04","kind":"exercise","planned":true,"acquired":false,"shares":3102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":401084,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":3102},"source":{"system":"sec-edgar","filing":"0001301120-25-000015","document":"wk-form4_1762374573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000015/wk-form4_1762374573.xml","form_type":"4"}},{"id":1006852,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-05T20:29:36.000Z","date":"2025-11-04","kind":"sale","planned":true,"acquired":false,"shares":3102,"price":4.3953,"value":13634.2206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.65 to $4.35. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000015","document":"wk-form4_1762374573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000015/wk-form4_1762374573.xml","form_type":"4"}},{"id":1006851,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-05T20:29:36.000Z","date":"2025-11-04","kind":"exercise","planned":true,"acquired":true,"shares":3102,"price":0.06,"value":186.12,"ownership":{"direct":true},"balance_after":3102,"source":{"system":"sec-edgar","filing":"0001301120-25-000015","document":"wk-form4_1762374573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000015/wk-form4_1762374573.xml","form_type":"4"}},{"id":1012067,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-29T21:04:10.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":false,"shares":5551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":404186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":5551},"source":{"system":"sec-edgar","filing":"0001301120-25-000013","document":"wk-form4_1761771847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000013/wk-form4_1761771847.xml","form_type":"4"}},{"id":1012066,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-29T21:04:10.000Z","date":"2025-10-28","kind":"sale","planned":true,"acquired":false,"shares":5551,"price":4.9615,"value":27541.2865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.9625 to $4.95. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000013","document":"wk-form4_1761771847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000013/wk-form4_1761771847.xml","form_type":"4"}},{"id":1012065,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-29T21:04:10.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":true,"shares":5551,"price":0.06,"value":333.06,"ownership":{"direct":true},"balance_after":5551,"source":{"system":"sec-edgar","filing":"0001301120-25-000013","document":"wk-form4_1761771847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000013/wk-form4_1761771847.xml","form_type":"4"}},{"id":1012592,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-28T17:22:22.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":false,"shares":949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":409737,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":949},"source":{"system":"sec-edgar","filing":"0001301120-25-000011","document":"wk-form4_1761672139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000011/wk-form4_1761672139.xml","form_type":"4"}},{"id":1012591,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-28T17:22:22.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":949,"price":5.1857,"value":4921.2293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.10. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000011","document":"wk-form4_1761672139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000011/wk-form4_1761672139.xml","form_type":"4"}},{"id":1012590,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-28T17:22:22.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":true,"shares":949,"price":0.06,"value":56.94,"ownership":{"direct":true},"balance_after":949,"source":{"system":"sec-edgar","filing":"0001301120-25-000011","document":"wk-form4_1761672139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000011/wk-form4_1761672139.xml","form_type":"4"}},{"id":1015263,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-21T16:24:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":410686,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001301120-25-000009","document":"wk-form4_1761063888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000009/wk-form4_1761063888.xml","form_type":"4"}},{"id":1015262,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-21T16:24:50.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":4.9672,"value":32286.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.02 to $4.88. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000009","document":"wk-form4_1761063888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000009/wk-form4_1761063888.xml","form_type":"4"}},{"id":1015261,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-21T16:24:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":0.06,"value":390.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001301120-25-000009","document":"wk-form4_1761063888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000009/wk-form4_1761063888.xml","form_type":"4"}},{"id":1019285,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-14T17:16:19.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":false,"shares":4326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":417186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":4326},"source":{"system":"sec-edgar","filing":"0001301120-25-000007","document":"wk-form4_1760462176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000007/wk-form4_1760462176.xml","form_type":"4"}},{"id":1019284,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-14T17:16:19.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":4326,"price":5.2,"value":22495.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.18. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000007","document":"wk-form4_1760462176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000007/wk-form4_1760462176.xml","form_type":"4"}},{"id":1019283,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-14T17:16:19.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":true,"shares":4326,"price":0.06,"value":259.56,"ownership":{"direct":true},"balance_after":4326,"source":{"system":"sec-edgar","filing":"0001301120-25-000007","document":"wk-form4_1760462176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000007/wk-form4_1760462176.xml","form_type":"4"}},{"id":1054559,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":false,"shares":45632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":421512,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":45632},"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1054558,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-25","kind":"exercise","planned":true,"acquired":false,"shares":2042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":467144,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2042},"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1054557,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":45632,"price":7.01,"value":319880.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $6.70. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1054556,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":2042,"price":5.65,"value":11537.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.70 to $5.65. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1054555,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":true,"shares":45632,"price":0.06,"value":2737.92,"ownership":{"direct":true},"balance_after":45632,"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1054554,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-27T21:16:39.000Z","date":"2025-08-25","kind":"exercise","planned":true,"acquired":true,"shares":2042,"price":0.06,"value":122.52,"ownership":{"direct":true},"balance_after":2042,"source":{"system":"sec-edgar","filing":"0001301120-25-000005","document":"wk-form4_1756329396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000130112025000005/wk-form4_1756329396.xml","form_type":"4"}},{"id":1060322,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T21:13:25.000Z","date":"2025-08-20","kind":"exercise","planned":true,"acquired":false,"shares":2077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":469186,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2077},"source":{"system":"sec-edgar","filing":"0001708599-25-000097","document":"wk-form4_1755724400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000097/wk-form4_1755724400.xml","form_type":"4"}},{"id":1060321,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T21:13:25.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":false,"shares":2227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options are fully vested."}],"balance_after":471263,"derivative":{"exercise_price":0.06,"expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":2227},"source":{"system":"sec-edgar","filing":"0001708599-25-000097","document":"wk-form4_1755724400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000097/wk-form4_1755724400.xml","form_type":"4"}},{"id":1060320,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:13:25.000Z","date":"2025-08-20","kind":"sale","planned":true,"acquired":false,"shares":2077,"price":5.1,"value":10592.7,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001708599-25-000097","document":"wk-form4_1755724400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000097/wk-form4_1755724400.xml","form_type":"4"}},{"id":1060319,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:13:25.000Z","date":"2025-08-20","kind":"exercise","planned":true,"acquired":true,"shares":2077,"price":0.06,"value":124.62,"ownership":{"direct":true},"balance_after":2077,"source":{"system":"sec-edgar","filing":"0001708599-25-000097","document":"wk-form4_1755724400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000097/wk-form4_1755724400.xml","form_type":"4"}},{"id":1060318,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":44235,"kind":"person","name":"Moreadith Randall","position":1,"cik":"0001301120","reported_name":"Moreadith Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:13:25.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":2227,"price":5.25,"value":11691.75,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001708599-25-000097","document":"wk-form4_1755724400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000097/wk-form4_1755724400.xml","form_type":"4"}}],"next_cursor":"2025-08-20T21:13:25.000000Z,1060318"}